Inducible Transgenic Rat Model for Diabetes Mellitus Based on shRNA-Mediated Gene Knockdown

The rat is an important animal model in biomedical research, but gene targeting technology is not established for this species. Therefore, we aimed to produce transgenic knockdown rats using shRNA technology and pronuclear microinjection. To this purpose, we employed a tetracycline-inducible shRNA expression system targeting the insulin receptor (IR). Doxycycline (DOX) treatment of the resulting transgenic rats led to a dose-dependent and reversible increase in blood glucose caused by ubiquitous inhibition of IR expression and signalling. We could neither detect an interferon response nor disturbances in microRNA processing after DOX treatment excluding toxic effects of shRNA expression. Low dose DOX treatment induced a chronic state of diabetes mellitus. In conclusion, we have developed a technology which allows the specific, inducible, and reversible suppression of any gene of interest in the rat. Our first transgenic rat line generated with this method represents an inducible model for diabetes mellitus.

[1]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[2]  S. Pignata,et al.  Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study , 2006, BMC Cancer.

[3]  Ming-Wei Wang,et al.  Development and application of rodent models for type 2 diabetes , 2005, Diabetes, obesity & metabolism.

[4]  X. Coumoul,et al.  Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference , 2005, Nucleic acids research.

[5]  A. McMahon,et al.  Reproducible and inducible knockdown of gene expression in mice , 2006, Genesis.

[6]  J. Alcolado,et al.  Animal models of diabetes mellitus , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[7]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[8]  C. Hsieh,et al.  Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts , 2008, Cell.

[9]  R. Hammer,et al.  Heritable and stable gene knockdown in rats. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Melov,et al.  Pol II–Expressed shRNA Knocks Down Sod2 Gene Expression and Causes Phenotypes of the Gene Knockout in Mice , 2005, PLoS genetics.

[11]  S. Lowe,et al.  Tissue-specific and reversible RNA interference in transgenic mice , 2007, Nature Genetics.

[12]  Anastasia Khvorova,et al.  Induction of the interferon response by siRNA is cell type- and duplex length-dependent. , 2006, RNA.

[13]  S. Lowe,et al.  Probing tumor phenotypes using stable and regulated synthetic microRNA precursors , 2005, Nature Genetics.

[14]  Edwin Cuppen,et al.  Progress and prospects in rat genetics: a community view , 2008, Nature Genetics.

[15]  R. Iggo,et al.  Induction of an interferon response by RNAi vectors in mammalian cells , 2003, Nature Genetics.

[16]  P. Sharp,et al.  Cre-lox-regulated conditional RNA interference from transgenes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Hannon,et al.  Germline transmission of RNAi in mice , 2003, Nature Structural Biology.

[18]  Hermann Bujard,et al.  Studying gene function in eukaryotes by conditional gene inactivation. , 2002, Annual review of genetics.

[19]  K. Taira,et al.  Transgenic Small Interfering RNA Halts Amyotrophic Lateral Sclerosis in a Mouse Model* , 2005, Journal of Biological Chemistry.

[20]  F. Luft,et al.  Endothelial Dysfunction and Elevated Blood Pressure in Mas Gene-Deleted Mice , 2008, Hypertension.

[21]  N. Alenina,et al.  Induction and analysis of cardiac hypertrophy in transgenic animal models. , 2005, Methods in molecular medicine.

[22]  R. Erickson,et al.  DNA constructs designed to produce short hairpin, interfering RNAs in transgenic mice sometimes show early lethality and an interferon response. , 2005, Journal of applied genetics.

[23]  Hermann Bujard,et al.  Tetracycline-regulated gene expression in the brain , 2000, Current Opinion in Neurobiology.

[24]  Jens C. Brüning,et al.  Single copy shRNA configuration for ubiquitous gene knockdown in mice , 2005, Nucleic acids research.

[25]  M. Gossen,et al.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Quail,et al.  Tn10-encoded tet repressor can regulate an operator-containing plant promoter. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Pumin Zhang,et al.  A transgenic approach for RNA interference-based genetic screening in mice , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Austin G Smith,et al.  Capture of Authentic Embryonic Stem Cells from Rat Blastocysts , 2008, Cell.

[29]  F. Leenders,et al.  Inducible shRNA expression for application in a prostate cancer mouse model. , 2003, Nucleic acids research.

[30]  M. Bader,et al.  Strain Differences in Superovulatory Response, Embryo Development and Efficiency of Transgenic Rat Production , 2005, Transgenic Research.

[31]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[32]  E. Jackson,et al.  Rat models of the metabolic syndrome. , 2003, Methods in molecular medicine.

[33]  E. Kruithof,et al.  Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors , 2004, BMC Molecular Biology.

[34]  Theresa A. Storm,et al.  Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways , 2006, Nature.

[35]  H. Reichardt,et al.  Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats , 2008, Proceedings of the National Academy of Sciences.

[36]  M. Gossen,et al.  Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.